Dermal Fillers and Botulinum Toxin Market by Product, Application & Region | Forecast 2022 to 2032
Get a Glimpse into Modern Consumers' Expectations for Cosmetic Procedures and Consumption Insights in FMI's Study for Dermal Fillers and Botulinum Toxins!
Dermal Fillers and Botulinum Toxin Market Outlook (2022 to 2032)
The dermal fillers and botulinum toxin market size is expected to reach a valuation of US$ 5.9 Billion by the end of 2022, and further expand at a CAGR of 6.1% from 2022 to 2032. The market is projected to reach a valuation of US$ 10.5 Billion by the end of 2032. Botulinum toxin is currently leading the dermal fillers and botulinum toxin market and it held a share of about 59.3% in 2021.
The global demand for dermal fillers and botulinum toxins is expected to rise along with increasing awareness about aesthetic beauty since there has been a significant surge in disposable income globally. Due to the increasing number of people choosing to enhance their aesthetic appearance, sales in the global dermal fillers and botulinum toxin market is expected to grow at a fast pace.
Attributes
Key Insights
Global Dermal Fillers and Botulinum Toxin Market Estimated Size (2022E)
US$ 5.9 Billion
Projected Market Valuation (2032F)
US$ 10.5 Billion
Value-based CAGR (2022 to 2032)
6.1%
Collective Value Share: Top 5 Countries
71.6%
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
2012 to 2021 Global Dermal Fillers and Botulinum Toxin Demand Outlook Compared to 2022 to 2032 Forecast
The global dermal fillers and botulinum toxin market hold approximately 23.1% of the global facial rejuvenation market, which was worth US$ 24.0 Billion in 2021. The global dermal fillers and botulinum toxin market expanded at a CAGR of 5.8% from 2012 to 2021.
Demand in the dermal fillers and botulinum toxin market will continue to remain strong, offsetting any industry margin compression. Additionally, increasing research & development (R&D) initiatives to extend the therapeutic botulinum applications of botulinum toxin and a rising number of cosmetic issues like lateral central lines and crow's feet on the face are some of the key drivers of the dermal fillers and botulinum toxin market.
Botulinum toxin is a non-invasive cosmetic procedure, which is used to treat a wide variety of cosmetic issues, including forehead creases and fine lines on the face. Due to its minimal pain and downtime, as well as its long-lasting effects, botulinum toxin treatments are becoming more popular among patients getting facelifts. As it has few side effects and can be used several times a year for maximum outcomes, Dysport (botulinum toxin) has received particularly positive reviews. This factor would further boost the sale of botulinum toxin treatments in the forecast period.
Top Trend Pushing Sales in Dermal Fillers and Botulinum Toxin Market
Urgent Need to Sculpt Facial Contours Will Drive Sales in the Market
People over the age of 40 years usually focus on their physical appearance and want to look young. Therefore, it is projected that increasing attention to aesthetic traits, particularly in developed nations, will accelerate the expansion of the dermal fillers and botulinum toxin market. In order to achieve an attractive, youthful facial appearance, dermal fillers, and botulinum toxins can be used to restore facial volume, reduce facial rhytides, and sculpt facial contours.
Additionally, social media has had a significant impact on consumers’ psychological health, encouraging them to begin these procedures as soon as possible to prevent the onset of age-related skin concerns as much as possible. This factor will further propel the need for dermal fillers and botulinum toxins in the next decade.
Moreover, owing to their improved effectiveness in a variety of treatment scenarios such as cleft lip correction and neck volume restoration, modern injectable treatments like dermal fillers are becoming more popular. Dermal fillers are used to treat acne scars, restore facial volume, diminish facial rhytides, and sculpt facial contours.
Consumers prefer a less painful, easier technique to appear younger and have aesthetically appealing facial features. This factor is anticipated to help dermal fillers and botulinum toxin manufacturers diversify their product portfolios. They are increasingly focusing on launching unique filler products with rising demand among people in developed countries.
Find your sweet spots for generating winning opportunities in this market.
Which Factors Are Restraining the Demand in Dermal Fillers and Botulinum Toxin Market?
In the anticipated time frame, market expansion may be hampered due to the high cost of botulinum toxin procedures. For instance, according to a report published by the American Society of Plastic Surgeons in 2020, the average cost of botulinum toxin injections is US$ 466.
The cost of a surgeon may vary depending on the procedure being performed, the surgeon's experience and qualification, as well as the amount of time and effort needed by the surgeon. Hence, this type of treatment is very expensive and will further hinder the expansion of the dermal fillers and botulinum toxin market.
Additionally, the low affordability of these procedures in emerging countries and among lower-income groups may inhibit the market’s expansion potential. The cost of botulinum toxin injections is also set to be affected by a wide variety of variables, including fine lines, the complexity of wrinkles, and how aggressively people want to treat the problem. Furthermore, dermal fillers and botulinum toxin treatments are becoming increasingly popular due to the increased desire for facial cosmetic surgery. However, both treatments have risky side effects, and a high dose of botulinum toxin can be fatal.
The clostridium botulinum bacteria produce protein and neurotoxin known as botulinum toxin. When injected into a muscle, it selectively inhibits the release of acetylcholine from nerve ends, blocking neural transmission.
Country-wise Insights
What Makes the USA a Large Hub for Dermal Fillers and Botulinum Toxins?
Demand for Minimally Invasive Hyaluronic Acid Fillers Surgeries to Grow in the USA
The USA held approximately 49.5% of the share in the global market in 2021 and is projected to witness constant profitable growth in the upcoming decade. Over the years, medical aesthetic technology in the USA has improved immensely and gained traction. For patients in need of medical aid, highly advanced technology in the country has provided them with a wide choice of products and solutions. Botulinum toxin has become widely used in cosmetic medicines in the USA During the forecast period, the market in the country is projected to develop rapidly due to the growing need for minimally invasive aesthetic operations.
How is Japan Emerging as a Prominent Industry for Dermal Fillers and Botulinum Toxins?
Availability of Anti-Ageing Therapies in Japan to Push the Need for Aesthetic Treatment
Japan held a market share of around 6.0% in 2021, says FMI. Increasing public awareness and a large young population will lead to more adoption of dermal fillers and botulinum toxin treatment. This factor is anticipated to boost the dermal fillers and botulinum toxin market expansion in Japan. Furthermore, the Japan market is anticipated to witness high demand with the rising need for advanced anti-aging therapies.
The rising purchasing power of the growing population is another crucial factor that would further drive the market. Additionally, the market value will be driven by the growing usage of modern technology and increased awareness about beauty enhancement techniques in the country.
What Makes Germany a Significant Dermal Fillers and Botulinum Toxin Industry?
Dermatological Clinics in Germany to Offer Advanced Cosmetic Procedures by 2032
Germany held approximately 5.0% of the share of the global market in 2021. Due to their high affordability, dermal fillers and botox treatments are showcasing considerable demand in Germany. There are several dermatological clinics, beauty parlors, and spas in Germany, which would further contribute to the country’s expanding need for botulinum toxin. Additionally, with the rising aging population and a growing desire for a younger appearance, Germany is likely to witness an increasing number of botulinum toxin-based treatments performed, which would further foster the demand for dermal fillers and botulinum toxins.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Category-wise Insights
Which are the Most Preferred Dermal Fillers and Botulinum Toxins Worldwide?
Demand for Botulinum Toxin Injections to Surge with the Need to Lower Facial Wrinkles
The botulinum toxin product segment is expected to witness high growth in the next decade. As per FMI, the segment held a market share of 59.3% in 2021 and is projected to exhibit growth at a CAGR of 5.3% in the global market during the forecast period. The main advantage of using botox injections is their ability to lessen the appearance of facial wrinkles, which would thus push growth in the segment.
Which is the Leading Application of Dermal Fillers and Botulinum Toxins?
Cosmetic Facial Fillers for Wrinkle Reduction Application to Gain Traction by 2032
Wrinkle reduction is expected to display a gradual growth rate over the forecast period. FMI mentions that the segment is projected to witness growth at a CAGR of 6.6% in the forecast period. With the rapidly changing lifestyles of people, the occurrence of wrinkles at the early stage of life is also growing. Wrinkle reduction is thus considered to be a booming aesthetic requirement nowadays, and the segment will further boost the dermal fillers and botulinum toxin market.
Competitive Landscape
The global dermal fillers and botulinum toxin market are highly fragmented with the presence of several competitors. These businesses are employing various strategies, including collaborations, partnerships, mergers & acquisitions, and new product launches to meet the rising consumer demand and increase their client base worldwide.
Some of the recent developments in the dermal fillers and botulinum toxin market are:
On 11 June 2021, Galderma announced the launch of Alluzience, the first ready-to-use neuromodulator or wrinkle-reducing injectable in Europe. Alluzience is a liquid version of botulinum toxin type A with a precision-designed formulation.
On 31 August 2021, Merz Pharma launched XEOMIN (incobotulinum toxin A) for the symptomatic treatment of chronic sialorrhea caused by neurological or other illnesses in children and adolescents aged 2 to 17 years with body weight less than 12 kg.
On 11 September 2019, Merz constructed a new plant in Dessau for its Belotero dermal fillers, expanding the range of products manufactured and 15 million Euros are invested to increase its presence in Biopharma Park.
Scope of the Dermal Fillers and Botulinum Toxin Market Report
Attribute
Details
Estimated Market Size (2022)
US$ 5.9 Billion
Projected Market Valuation (2032)
US$ 10.5 Billion
Value-based CAGR (2022 to 2032)
6.1%
Forecast Period
2022 to 2032
Historical Data Available for
2012 to 2021
Market Analysis
Value (US$ Billion)
Key Regions Covered
North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa
Key Countries Covered
USA, Canada Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, North Africa, and South Africa
Key Market Segments Covered
Product, Application, and Region
Key Companies Profiled
Allergan plc.
Galderma SA
Merz Pharma GmbH & Co. KGaA
Anika Therapeutics, Inc.
Suneva Medical, Inc.
Speciality European Pharma
HUGEL, Inc
Grex Pharma SaS
Daewoong Pharmaceuticals
Medy-Tox Inc.
TEOXANE Laboratories
SciVision Biotech Inc.
Ipsen SA
Report Coverage
Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Key Segments Covered in Dermal Fillers and Botulinum Toxin Market Research Report
By Product:
Hyaluronic Acid Based Dermal Fillers
Non-hyaluronic Acid Based Dermal Fillers
Botulinum Toxin
By Application:
Aesthetic Volume Restoration
Wrinkle Reduction
By Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)
Frequently Asked Questions
How much was the dermal fillers and botulinum toxin market worth in 2021?
The global dermal fillers and botulinum toxin market was worth US$ 5.6 Billion in 2021 and is set to expand 1.8x over the next ten years.
What is the sales forecast for the dermal fillers and botulinum toxin market through 2032?
The dermal fillers and botulinum toxin market is expected to reach US$ 10.5 Billion by the end of 2032, with sales revenue likely to register a 6.1% CAGR from 2022 to 2032.
What was the historical CAGR of the dermal fillers and botulinum toxin market?
From 2012 to 2021, the dermal fillers and botulinum toxin market expanded at a CAGR of 5.8%.
What is the North America dermal fillers and botulinum toxin market outlook?
North America is one of the key markets for dermal fillers and botulinum toxins and the USA accounted for about 89.3% of the North America dermal fillers and botulinum toxin market share in 2021.
At what CAGR is the dermal fillers and botulinum toxin market expected to register growth in the United Kingdom?
The dermal fillers and botulinum toxin market in the United Kingdom are expected to register growth at a CAGR of 7.0% over the next ten years.
Which countries are the key producers of dermal fillers and botulinum toxins?
The USA and Japan are the key producers of dermal fillers and botulinum toxins.
Who are the key players in the dermal fillers and botulinum toxin market?
Allergan plc, Galderma SA, Merz Pharma GmbH & Co. KGaA, Anika Therapeutics, Inc., Suneva Medical, Inc., and Speciality European Pharma are some of the key players in the dermal fillers and botulinum toxin market.
How likely is the dermal fillers and botulinum toxin market set to grow in Japan?
Japan accounted for about 6.0% of dermal fillers and botulinum toxin market share in 2021.
What is the outlook of China in the global dermal fillers and botulinum toxin market?
The dermal fillers and botulinum toxin market in China is set to expand at a CAGR of 6.1% over the projected period.
What is the outlook of India in the global dermal fillers and botulinum toxin market?
The dermal fillers and botulinum toxin market in India is anticipated to grow at a CAGR of 5.9% over the projected period.
Table of Content
1. Executive Summary | Dermal Fillers and Botulinum Toxin Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Technological Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Development/Innovation Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. New Product Launches
4.3. Value chain Analysis
4.4. PESTEL Analysis
4.5. Porter’s Analysis
4.6. Product Features/ USPs
4.7. Key Promotional Strategies, By Key Manufacturers
4.8. Regulatory Landscape
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure
5.1.3. Global Facial Rejuvenation Market Overview
5.2. Forecast Factors - Relevance & Impact
5.2.1. Key Player’s Historic Growth
5.2.2. Market Consolidation Activities
5.2.3. New Product Launches / Approvals
5.2.4. Growing Awareness Regarding Aesthetical Appearance
5.2.5. Increasing Demand for Dermal Fillers and Botulinum Toxin
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis - Impact Assessment
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Application
6.1.3. By Region
6.2. 2021 Market Scenario
7. Global Market Demand Value or Size (US$ Million) Analysis 2012 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Value (US$ Million) Analysis, 2012 to 2021
7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis By Product, 2012 to 2021
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product, 2022 to 2032
8.3.1. Hyaluronic Acid-Based Dermal Fillers
8.3.2. Non-Hyaluronic Acid-Based Dermal Fillers
8.3.3. Botulinum Toxin
8.4. Market Attractiveness Analysis By Product
9. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) By Application, 2012 to 2021
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2022 to 2032
9.3.1. Aesthetic Volume Restoration
9.3.2. Wrinkle Reduction
9.4. Market Attractiveness Analysis By Application
10. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Region
10.1. Introduction
10.2. Historical Market Size (US$ Million) Trend Analysis by Region, 2012 to 2021
10.3. Current Market Size (US$ Million) Analysis and Forecast by Region, 2022 to 2032
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. South Asia
10.3.5. East Asia
10.3.6. Oceania
10.3.7. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2012 to 2021 and Forecast 2022 to 2032
11.1. Introduction
11.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
11.3. Current and Future Market Size (US$ Million) Forecast by Market Taxonomy, 2022 to 2032
11.3.1. By Country
11.3.1.1. USA
11.3.1.2. Canada
11.3.2. By Product
11.3.3. By Application
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Product
11.4.3. By Application
11.5. Market Trends
11.6. Key Market Participants - Intensity Mapping
11.7. Drivers and Restraints - Impact Analysis
11.8. Country-Level Analysis & Forecast
11.8.1. USA Market Analysis
11.8.1.1. Introduction
11.8.1.2. Market Analysis and Forecast by Market Taxonomy
11.8.1.2.1. By Product
11.8.1.2.2. By Application
11.8.2. Canada Market Analysis
11.8.2.1. Introduction
11.8.2.2. Market Analysis and Forecast by Market Taxonomy
11.8.2.2.1. By Product
11.8.2.2.2. By Application
12. Latin America Market Analysis 2012 to 2021 and Forecast 2022 to 2032
12.1. Introduction
12.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. By Product
12.3.3. By Application
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product
12.4.3. By Application
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country-Level Analysis & Forecast
12.8.1. Brazil Market Analysis
12.8.1.1. Introduction
12.8.1.2. Market Analysis and Forecast by Market Taxonomy
12.8.1.2.1. By Product
12.8.1.2.2. By Application
12.8.2. Mexico Market Analysis
12.8.2.1. Introduction
12.8.2.2. Market Analysis and Forecast by Market Taxonomy
12.8.2.2.1. By Product
12.8.2.2.2. By Application
12.8.3. Argentina Market Analysis
12.8.3.1. Introduction
12.8.3.2. Market Analysis and Forecast by Market Taxonomy
12.8.3.2.1. By Product
12.8.3.2.2. By Application
13. Europe Market Analysis 2012 to 2021 and Forecast 2022 to 2032
13.1. Introduction
13.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. Italy
13.3.1.3. France
13.3.1.4. United Kingdom
13.3.1.5. Spain
13.3.1.6. BENELUX
13.3.1.7. Nordic Countries
13.3.1.8. Russia
13.3.1.9. Rest of Europe
13.3.2. By Product
13.3.3. By Application
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Application
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country-Level Analysis & Forecast
13.8.1. Germany Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Product
13.8.1.2.2. By Application
13.8.2. Italy Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Product
13.8.2.2.2. By Application
13.8.3. France Market Analysis
13.8.3.1. Introduction
13.8.3.2. Market Analysis and Forecast by Market Taxonomy
13.8.3.2.1. By Product
13.8.3.2.2. By Application
13.8.4. United Kingdom Market Analysis
13.8.4.1. Introduction
13.8.4.2. Market Analysis and Forecast by Market Taxonomy
13.8.4.2.1. By Product
13.8.4.2.2. By Application
13.8.5. Spain Market Analysis
13.8.5.1. Introduction
13.8.5.2. Market Analysis and Forecast by Market Taxonomy
13.8.5.2.1. By Product
13.8.5.2.2. By Application
13.8.6. BENELUX Market Analysis
13.8.6.1. Introduction
13.8.6.2. Market Analysis and Forecast by Market Taxonomy
13.8.6.2.1. By Product
13.8.6.2.2. By Application
13.8.7. Nordic Countries Market Analysis
13.8.7.1. Introduction
13.8.7.2. Market Analysis and Forecast by Market Taxonomy
13.8.7.2.1. By Product
13.8.7.2.2. By Application
13.8.8. Russia Market Analysis
13.8.8.1. Introduction
13.8.8.2. Market Analysis and Forecast by Market Taxonomy
13.8.8.2.1. By Product
13.8.8.2.2. By Application
14. South Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032
14.1. Introduction
14.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
14.3.1. By Country
14.3.1.1. India
14.3.1.2. Indonesia
14.3.1.3. Thailand
14.3.1.4. Malaysia
14.3.1.5. Rest of South Asia
14.3.2. By Product
14.3.3. By Application
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Application
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country-Level Analysis & Forecast
14.8.1. India Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Application
14.8.2. Indonesia Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Application
14.8.3. Thailand Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Product
14.8.3.2.2. By Application
14.8.4. Malaysia Market Analysis
14.8.4.1. Introduction
14.8.4.2. Market Analysis and Forecast by Market Taxonomy
14.8.4.2.1. By Product
14.8.4.2.2. By Application
15. East Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032
15.1. Introduction
15.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
15.3. Current and Future Market Size (US$ Million) Forecast by Market Taxonomy, 2022 to 2032
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Product
15.3.3. By Application
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Application
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country-Level Analysis & Forecast
15.8.1. China Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Application
15.8.2. Japan Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Application
15.8.3. South Korea Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Application
16. Oceania Market 2012 to 2021 and Forecast 2022 to 2032
16.1. Introduction
16.2. Historical Market Size (US$ Million) by Market Taxonomy, 2012 to 2021
16.3. Current and Future Market Size (US$ Million) and Forecast by Market Taxonomy, 2022 to 2032
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Product
16.3.3. By Application
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Application
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country-Level Analysis & Forecast
16.8.1. Australia Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Application
16.8.2. New Zealand Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Application
17. Middle East and Africa (MEA) Market Analysis 2012 to 2021 and Forecast 2022 to 2032
17.1. Introduction
17.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
17.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Turkey
17.3.1.3. South Africa
17.3.1.4. North Africa
17.3.1.5. Rest of Middle East and Africa
17.3.2. By Product
17.3.3. By Application
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Application
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country-Level Analysis & Forecast
17.8.1. GCC Countries Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Application
17.8.2. Turkey Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Application
17.8.3. South Africa Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Application
17.8.4. North Africa Market Analysis
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast by Market Taxonomy
17.8.4.2.1. By Product
17.8.4.2.2. By Application
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Share Analysis of Top Players (%)
18.3. Market Presence Analysis
18.3.1. By Regional Footprint of Players
18.3.2. Product Footprint of Players
18.3.3. Channel Footprint of Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. Allergan plc.
19.3.1.1. Overview
19.3.1.2. Product & Services Portfolio
19.3.1.3. Key Financials
19.3.1.4. SWOT Analysis
19.3.1.5. Key Developments
19.3.1.6. Sales Footprint
19.3.1.7. Strategy Overview
19.3.1.7.1. Marketing Strategy
19.3.1.7.2. Product Strategy
19.3.1.7.3. Channel Strategy
19.3.2. Galderma SA
19.3.2.1. Overview
19.3.2.2. Product & Services Portfolio
19.3.2.3. Key Financials
19.3.2.4. SWOT Analysis
19.3.2.5. Key Developments
19.3.2.6. Sales Footprint
19.3.2.7. Strategy Overview
19.3.2.7.1. Marketing Strategy
19.3.2.7.2. Product Strategy
19.3.2.7.3. Channel Strategy
19.3.3. Merz Pharma GmbH & Co. KGaA
19.3.3.1. Overview
19.3.3.2. Product & Services Portfolio
19.3.3.3. Key Financials
19.3.3.4. SWOT Analysis
19.3.3.5. Key Developments
19.3.3.6. Sales Footprint
19.3.3.7. Strategy Overview
19.3.3.7.1. Marketing Strategy
19.3.3.7.2. Product Strategy
19.3.3.7.3. Channel Strategy
19.3.4. Anika Therapeutics, Inc.
19.3.4.1. Overview
19.3.4.2. Product & Services Portfolio
19.3.4.3. Key Financials
19.3.4.4. SWOT Analysis
19.3.4.5. Key Developments
19.3.4.6. Sales Footprint
19.3.4.7. Strategy Overview
19.3.4.7.1. Marketing Strategy
19.3.4.7.2. Product Strategy
19.3.4.7.3. Channel Strategy
19.3.5. Suneva Medical, Inc.
19.3.5.1. Overview
19.3.5.2. Product & Services Portfolio
19.3.5.3. Key Financials
19.3.5.4. SWOT Analysis
19.3.5.5. Key Developments
19.3.5.6. Sales Footprint
19.3.5.7. Strategy Overview
19.3.5.7.1. Marketing Strategy
19.3.5.7.2. Product Strategy
19.3.5.7.3. Channel Strategy
19.3.6. Speciality European Pharma
19.3.6.1. Overview
19.3.6.2. Product & Services Portfolio
19.3.6.3. Key Financials
19.3.6.4. SWOT Analysis
19.3.6.5. Key Developments
19.3.6.6. Sales Footprint
19.3.6.7. Strategy Overview
19.3.6.7.1. Marketing Strategy
19.3.6.7.2. Product Strategy
19.3.6.7.3. Channel Strategy
19.3.7. HUGEL, Inc
19.3.7.1. Overview
19.3.7.2. Product & Services Portfolio
19.3.7.3. Key Financials
19.3.7.4. SWOT Analysis
19.3.7.5. Key Developments
19.3.7.6. Sales Footprint
19.3.7.7. Strategy Overview
19.3.7.7.1. Marketing Strategy
19.3.7.7.2. Product Strategy
19.3.7.7.3. Channel Strategy
19.3.8. Grex Pharma SaS
19.3.8.1. Overview
19.3.8.2. Product & Services Portfolio
19.3.8.3. Key Financials
19.3.8.4. SWOT Analysis
19.3.8.5. Key Developments
19.3.8.6. Sales Footprint
19.3.8.7. Strategy Overview
19.3.8.7.1. Marketing Strategy
19.3.8.7.2. Product Strategy
19.3.8.7.3. Channel Strategy
19.3.9. Daewoong Pharmaceuticals
19.3.9.1. Overview
19.3.9.2. Product & Services Portfolio
19.3.9.3. Key Financials
19.3.9.4. SWOT Analysis
19.3.9.5. Key Developments
19.3.9.6. Sales Footprint
19.3.9.7. Strategy Overview
19.3.9.7.1. Marketing Strategy
19.3.9.7.2. Product Strategy
19.3.9.7.3. Channel Strategy
19.3.10. Medy-Tox Inc.
19.3.10.1. Overview
19.3.10.2. Product & Services Portfolio
19.3.10.3. Key Financials
19.3.10.4. SWOT Analysis
19.3.10.5. Key Developments
19.3.10.6. Sales Footprint
19.3.10.7. Strategy Overview
19.3.10.7.1. Marketing Strategy
19.3.10.7.2. Product Strategy
19.3.10.7.3. Channel Strategy
19.3.11. TEOXANE Laboratories
19.3.11.1. Overview
19.3.11.2. Product & Services Portfolio
19.3.11.3. Key Financials
19.3.11.4. SWOT Analysis
19.3.11.5. Key Developments
19.3.11.6. Sales Footprint
19.3.11.7. Strategy Overview
19.3.11.7.1. Marketing Strategy
19.3.11.7.2. Product Strategy
19.3.11.7.3. Channel Strategy
19.3.12. SciVision Biotech Inc.
19.3.12.1. Overview
19.3.12.2. Product & Services Portfolio
19.3.12.3. Key Financials
19.3.12.4. SWOT Analysis
19.3.12.5. Key Developments
19.3.12.6. Sales Footprint
19.3.12.7. Strategy Overview
19.3.12.7.1. Marketing Strategy
19.3.12.7.2. Product Strategy
19.3.12.7.3. Channel Strategy
19.3.13. Ipsen SA
19.3.13.1. Overview
19.3.13.2. Product & Services Portfolio
19.3.13.3. Key Financials
19.3.13.4. SWOT Analysis
19.3.13.5. Key Developments
19.3.13.6. Sales Footprint
19.3.13.7. Strategy Overview
19.3.13.7.1. Marketing Strategy
19.3.13.7.2. Product Strategy
19.3.13.7.3. Channel Strategy
20. Assumptions and Acronyms Used21. Research Methodology
